Galena Biopharma to Report Second Quarter 2014 Financial Results on Monday, August 11, 2014
July 29 2014 - 7:05AM
Galena Biopharma, Inc. (Nasdaq:GALE), a biopharmaceutical company
developing and commercializing innovative, targeted oncology
treatments that address major unmet medical needs to advance cancer
care, today announced that the Company will report its second
quarter financial results on Monday, August 11, 2014 after the
close of the financial markets. The company will host a conference
call following the announcement at 2:00 p.m. P.T./5:00 pm E.T. to
discuss financial and business results.
The conference call can be accessed by dialing (844) 825-4413
toll-free in the United States, or (973) 638-3403 for participants
outside the U.S. The Conference ID number is: 78727492. The
conference call will also be webcast live and available under the
Investors section/Events and Presentations on the Company's website
at www.galenabiopharma.com. The archived webcast replay will be
available on the Company's website for 90 days.
About Galena Biopharma
Galena Biopharma, Inc. (Nasdaq:GALE) is a Portland, Oregon-based
biopharmaceutical company developing and commercializing
innovative, targeted oncology treatments that address major unmet
medical needs to advance cancer care. For more information
please visit: www.galenabiopharma.com.
CONTACT: Remy Bernarda
Vice President, Marketing & Communications
(503) 405-8258
rbernarda@galenabiopharma.com
SELLAS Life Sciences (NASDAQ:SLS)
Historical Stock Chart
From Aug 2024 to Sep 2024
SELLAS Life Sciences (NASDAQ:SLS)
Historical Stock Chart
From Sep 2023 to Sep 2024